Live feed
Filing
SC 13D/A
SC 13D/A0001104659-19-020047·Novartis Bioventures Ltd
Schedule 13D ownership disclosure
Tokai Pharmaceuticals Inc
Security class unavailable · CUSIP: 88907J107
Event date: 2019-04-04
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 469,652
- Percent of class
- 4.9800%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-19-020047
- Form type
- SC 13D/A
- Filer
- Novartis Bioventures Ltd
- CIK
- CIK 1297709
- Filed
- Apr 05, 2019
- Reporting period
- Apr 04, 2019
- Description
- Schedule 13D beneficial ownership